Esophageal cancer: Treatment Journal Article


Authors: Ku, G. Y.; Ilson, D. H.
Article Title: Esophageal cancer: Treatment
Abstract: Esophageal cancer is an uncommon cancer in the U.S., although the incidence of adenocarcinomas of the lower esophagus and gastroesophageal junction has steadily increased since the 1970s. Globally, esophageal cancer (mostly squamous cell carcinomas) is endemic in parts of the world, such as East Asia. In this review article, we discuss chemotherapy options in the metastatic setting as well as targeted agents that are currently approved. We then focus on validated pre-, peri- or post-operative strategies for locally advanced disease, which include chemotherapy and/or chemoradiation. © 2014 Elsevier Inc. All rights reserved.
Keywords: squamous cell carcinoma; chemotherapy; adenocarcinoma; targeted therapy; chemoradiation; esophageal cancer
Journal Title: Reference Module in Biomedical Sciences
ISSN: 978-0-12-801238-3
Publisher: Elsevier Inc.  
Date Published: 2014-01-01
Language: English
DOI: 10.1016/b978-0-12-801238-3.04336-1
PROVIDER: scopus
DOI/URL:
Notes: This is an update of "Ilson DH, Kelsen D. Esophageal cancer: Treatment. In: Bertino JR, editor. Encyclopedia of cancer, 2nd ed. San Diego: Academic Press; 2002. p. 169-177," published for Elsevier's Reference Modules on Science Direct -- Export Date: 2 December 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Geoffrey Yuyat Ku
    230 Ku
  2. David H Ilson
    433 Ilson
Related MSK Work